• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

Pediatric Narcolepsy Severity Scale Gains Credibility

September 13, 2021 by admin

As reported by NeurologyLive® and the American Journal of Managed Care (AJMC), the novel Pediatric Narcolepsy Severity Scale (NSS-P) was recently shown to provide adequate psychometric properties and temporal stability in the assessment of more than 150 children and adolescents with narcolepsy type 1.

“Spotlighting the potential of a scale tailored toward pediatric populations, NSS-P was reformulated from the original NSS and provided self-reported sleepiness, insomnia, and depressive symptoms of school-aged children and adolescents diagnosed in 3 reference centers for narcolepsy in France,” writes Matthew Gavidia of AJMC. “Notably, the scale may be unreliable in those under the age of 10, as young children may have difficulty in recognizing and quantifying symptoms such as cataplexy. Symptoms associated with NT1, including fatigue, brain fog, and autonomic behaviors, were also noted to not be evaluated by the NSS-P questionnaire.” 

Differences in sleep phenotypes characteristic of moderate to severe obstructive sleep apnea (OSA) between white and hispanic/latino patients may warrant the integration of new classification classes in these populations, according to study findings published in Sleep. “As reported by NeurologyLive®, data derived from the Sleep Apnea Global Interdisciplinary Consortium on primarily non-Hispanic White and Asian participants recommended the categorization of OSA into 5 symptom classes,” adds Gavidia. “Conversely, analysis of the Hispanic Community Health Study/Study of Latinos on Hispanic/Latino patients identified 3 phenotypes for categorization, including minimally symptomatic (47.7%), excessive sleepiness (37.1%), and disturbed sleep (15.2%).” 

Filed Under: Blog Tagged With: narcolepsy

Primary Sidebar

More to See

Xywav Oral Solution for Idiopathic Hypersomnia

February 16, 2022 By Alan Hickey

New Insomnia Drug Improves Sleep Outcomes for Adults

February 10, 2022 By Alan Hickey

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep industry Sleepiness sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • Sleep Hygiene: Which Bedroom Colors to Avoid and which Promote Good Sleep??
  • Xywav Oral Solution for Idiopathic Hypersomnia
  • New Insomnia Drug Improves Sleep Outcomes for Adults
  • Mark Cuban Billionaire Entrepreneur and Television Personality Launches Online Pharmacy for Generic Drugs
  • Americans Say They’re Sleep-Deprived After the Super Bowl

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2022 · Sleep Diagnosis and Therapy